Trefoil Therapeutics Announces Third Tranche Of $28 Million Series A Financing Based On Achievement Of Clinical Trial Objectives
Amount Raised
$28 Million
Round Type
Series A
Description
Trefoil Therapeutics today announced that after review of the interim clinical data from the INTREPID and STORM studies, the Series A investors have funded the third tranche of its $28 million Series A financing to support the development of its engineered FGF-1, TTHX1114 products for the regenerative treatment of corneal diseases. This funding allows Trefoil to expand the STORM clinical program and initiate a clinical trial of the topical formulation.
Quick answer
Trefoil Therapeutics raised $28 Million in a Series A round, dated December 1, 2021. Trefoil Therapeutics is based in El Cajon, California, United States.
- How much did Trefoil Therapeutics raise?
- Trefoil Therapeutics raised $28 Million in a Series A round on December 1, 2021.
- What does Trefoil Therapeutics do?
- Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of regenerative therapies.
- Where is Trefoil Therapeutics based and how big is it?
- Trefoil Therapeutics is based in El Cajon, California, United States.
- Who are the decision-makers at Trefoil Therapeutics?
- Fundz holds 1 contact at Trefoil Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Trefoil Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Arda Therapeutics raised $7.5M on January 14, 2022.
- Co-Diagnostics, Inc. raised $47M on January 14, 2022.
- DermBiont raised $33M (Seed) on January 14, 2022.
- PostEra Inc. raised $26M on January 14, 2022.
- Alterome Therapeutics, Inc. raised $64M on January 14, 2022.
- Qualia Oto, Inc. raised $1.4M (Seed) on January 14, 2022.
Who to call at Trefoil Therapeutics, and when
A new round usually means Trefoil Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Trefoil Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Trefoil Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Trefoil Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Trefoil Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTrefoil Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.